A photo of a sign for Eli Lilly & Co. outside their corporate headquarters in Indianapolis.
Gisèle Pelicot thanks backers after her ex-husband and his co-defendants are convicted in rape trialProsecutor Fani Willis is removed from the Georgia election case against Trump and othersThe Afternoon WireFriedkin Group completes purchase of Everton and becomes 10th US owner in Premier LeagueQuestlove readies new documentary spotlighting 'Saturday Night Live' music performancesBiden pledges to cut US greenhouse gases by more than 60% as he exits the world stageA new neutrino...
The FDA said Thursday that “Lilly’s supply is currently meeting or exceeding demand,” after two years of shortages. Thursday’s decision gives businesses between 60 and 90 days, depending on their size, to phase out their products.
Eli Lilly Corporate Headquarters Indianapolis Pharmaceuticals
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trialEli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.
Read more »
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, ZepboundEli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Read more »
China Approves Eli Lilly's Donanemab for Early Alzheimer'sChina's food and drug regulator has approved Eli Lilly's Kisunla (donanemab) treatment for early symptomatic Alzheimer's disease, marking the fourth major market to grant approval. This follows approvals in the U.S., Japan, and the UK earlier this year. Donanemab targets beta amyloid, clearing it from the brain and differs from Leqembi in requiring finite dosing once plaques are cleared.
Read more »
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, ZepboundEli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Read more »
Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly roseOracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose
Read more »
FDA says Eli Lilly's weight loss drug Zepbound is no longer in shortageThe decision that will eventually bar compounding pharmacies from making unbranded versions of the injection.
Read more »